SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-031425
Filing Date
2023-11-13
Accepted
2023-11-13 09:12:50
Documents
14
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20231108_8k.htm   iXBRL 8-K 24806
2 PRESS RELEASE ISSUED BY PULSE BIOSCIENCES, INC. DATED NOVEMBER 13, 2023 ex_594308.htm EX-99.1 292919
  Complete submission text file 0001437749-23-031425.txt   469715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plse-20231113.xsd EX-101.SCH 3411
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20231113_def.xml EX-101.DEF 11426
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20231113_lab.xml EX-101.LAB 15312
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20231113_pre.xml EX-101.PRE 11586
8 EXTRACTED XBRL INSTANCE DOCUMENT plse20231108_8k_htm.xml XML 2555
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 231395712
SIC: 3841 Surgical & Medical Instruments & Apparatus